Expressing the sense of the House of Representatives that Thomas Garrett was and should be recognized as a national abolitionist leader and activist in the struggle against slavery in the United States.
Drug Pricing Transparency and Accountability Act This bill establishes a two-year moratorium on allowing new, non-rural hospitals and associated child sites to participate in the 340B drug pricing program; during the moratorium, the Department of Health and Human Services must issue regulations with specified program eligibility standards. The bill also requires additional reporting relating to program participation, eligibility, and costs.